Patients with other hepatobiliary diseases can also have liver fibrosis and elevated MMP-7 levels, however, around the cutoff value, indicating that the regulatory pathways of MMP-7 in non-BA may be different from those associated with BA. This evidence concerns the gene MMP7 and breast angiosarcoma.